However, unlike anti-AQP4 antibodies which attack the astrocytic AQP4 protein, anti-MOG antibodies attack a protein expressed on the outer surface of the myelin, leading to greatly demyelinating episodes than NMOSD; therefore, on the immunopathological side it is closer to MS [82,88]. The gene discussed is MOG; the disease is myeloid sarcoma.